Laporte Kathleen - Director at Cero Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CERO, CEROW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Laporte Kathleen since 9/17/2023

Holdings reported by Laporte Kathleen for Cero Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 113K Mar 25, 2024 Direct Common Stock
Common Stock 5.83K Feb 14, 2024 Direct
Series A Convertible Preferred Stock 50 Feb 14, 2024 By the Kathleen LaPorte Revocable Trust Common Stock

Transactions reported by Laporte Kathleen for Cero Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.